BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14744481)

  • 1. Starch acetate as a tablet matrix for sustained drug release.
    Pohja S; Suihko E; Vidgren M; Paronen P; Ketolainen J
    J Control Release; 2004 Feb; 94(2-3):293-302. PubMed ID: 14744481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug release from starch-acetate films.
    Tuovinen L; Peltonen S; Järvinen K
    J Control Release; 2003 Sep; 91(3):345-54. PubMed ID: 12932712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous starch acetate dispersion as a novel coating material for controlled release products.
    Tarvainen M; Peltonen S; Mikkonen H; Elovaara M; Tuunainen M; Paronen P; Ketolainen J; Sutinen R
    J Control Release; 2004 Apr; 96(1):179-91. PubMed ID: 15063040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase.
    Tuovinen L; Peltonen S; Liikola M; Hotakainen M; Lahtela-Kakkonen M; Poso A; Järvinen K
    Biomaterials; 2004 Aug; 25(18):4355-62. PubMed ID: 15046926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.
    Mäki R; Suihko E; Rost S; Heiskanen M; Murtomaa M; Lehto VP; Ketolainen J
    J Pharm Sci; 2007 Feb; 96(2):438-47. PubMed ID: 17075868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of saccharides from matrix tablets.
    Mäki R; Suihko E; Korhonen O; Pitkänen H; Niemi R; Lehtonen M; Ketolainen J
    Eur J Pharm Biopharm; 2006 Feb; 62(2):163-70. PubMed ID: 16343875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release multiparticulate beads coated with starch acetate: material characterization, and identification of critical formulation and process variables.
    Nutan MT; Vaithiyalingam SR; Khan MA
    Pharm Dev Technol; 2007; 12(3):307-20. PubMed ID: 17613894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
    van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
    Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpolymer complexation between copovidone and carbopol and its effect on drug release from matrix tablets.
    Zhang F; Meng F; Wang ZY; Na W
    Drug Dev Ind Pharm; 2017 Feb; 43(2):190-203. PubMed ID: 27599027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylation enhances the tabletting properties of starch.
    Raatikainen P; Korhonen O; Peltonen S; Parone P
    Drug Dev Ind Pharm; 2002; 28(2):165-75. PubMed ID: 11926361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
    Al-Zoubi NM; AlKhatib HS; Obeidat WM
    Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.
    Korhonen O; Kanerva H; Vidgren M; Urtti A; Ketolainen J
    J Control Release; 2004 Mar; 95(3):515-20. PubMed ID: 15023462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation and Evaluation of Taro Boloso-I Starch as Directly Compressible Excipient in Tablet Formulation.
    Getachew A; Yilma Z; Abrha S
    Adv Pharmacol Pharm Sci; 2020; 2020():2708063. PubMed ID: 32259101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Evaluation of amorphous debranched starch as extended-release matrices in tablets.
    Liu G; Hong Y; Gu Z
    Carbohydr Polym; 2013 Oct; 98(1):995-1001. PubMed ID: 23987439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release.
    Geresh S; Gdalevsky GY; Gilboa I; Voorspoels J; Remon JP; Kost J
    J Control Release; 2004 Feb; 94(2-3):391-9. PubMed ID: 14744489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospun starch acetate nanofibers: development, properties, and potential application in drug delivery.
    Xu W; Yang W; Yang Y
    Biotechnol Prog; 2009; 25(6):1788-95. PubMed ID: 19637387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Starch acetate--a novel film-forming polymer for pharmaceutical coatings.
    Tarvainen M; Sutinen R; Peltonen S; Tiihonen P; Paronen P
    J Pharm Sci; 2002 Jan; 91(1):282-9. PubMed ID: 11782918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.